Article Text

Download PDFPDF
Education in practice
Guidance on the effective use of upper gastrointestinal histopathology
  1. Maurice B Loughrey1,
  2. Brian T Johnston2
  1. 1Department of Histopathology, Royal Victoria Hospital, Belfast Trust, Belfast, UK
  2. 2Department of Gastroenterology, Royal Victoria Hospital, Belfast Trust, Belfast, UK
  1. Correspondence to Dr Maurice Loughrey, Institute of Pathology, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, UK; maurice.loughrey{at}


Given the ever-increasing demand for upper gastrointestinal endoscopy, for diagnosis and surveillance, there is a need to consider when it is appropriate, and when it is not appropriate, to take an endoscopic biopsy for histological evaluation. In this article, we consider this in relation to each of the anatomical compartments encountered during oesophagogastroduodenoscopy, and in relation to the common clinical scenarios and endoscopic abnormalities encountered. There are clear indications to biopsy suspicious ulceration or mass lesions and for investigation of some inflammatory conditions, such as eosinophilic oesophagitis and coeliac disease. Increasing guidance is available on optimal biopsy sites and biopsy numbers to maximise yield from histology. Outside these areas, the endoscopist should consider whether biopsy of normal or abnormal appearing mucosa is likely to contribute to patient management, to ensure effective use of limited healthcare resources.

  • Endoscopy
  • Histopathology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles